Homestead Advisers Corp Bristol Myers Squibb CO Transaction History

Homestead Advisers Corp

$3.87 Billion
Q1 2025

A detailed history of Homestead Advisers Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Homestead Advisers Corp holds 960,489 shares of BMY stock, worth $45.1 Million. This represents 1.51% of its overall portfolio holdings.

Number of Shares

960,489

Previous 960,489 -0.0%

Holding current value

$45.1 Million

Previous $54.3 Million 7.83%

% of portfolio

1.51%

Previous 1.37%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$51.92 - $59.94 $1.86 Million - $2.15 Million	35,800 Added 3.87%	960,489 $54.3 Million
Q3 2024 Nov 01, 2024	SELL	$39.66 - $51.75 $27,761 - $36,225	-700 Reduced 0.08%	924,689 $47.9 Million
Q2 2024 Jul 23, 2024	SELL	$40.25 - $52.99 $639,975 - $842,541	-15,900 Reduced 1.69%	925,389 $38.4 Million
Q1 2024 May 10, 2024	SELL	$47.98 - $54.4 $62,373 - $70,720	-1,300 Reduced 0.14%	941,289 $51 Million
Q4 2023 Feb 13, 2024	BUY	$48.48 - $57.85 $77,568 - $92,560	1,600 Added 0.17%	942,589 $48.4 Million
Q3 2023 Nov 09, 2023	BUY	$57.89 - $64.73 $839,405 - $938,585	14,500 Added 1.57%	940,989 $54.6 Million
Q2 2023 Jul 25, 2023	BUY	$63.71 - $70.74 $286,695 - $318,330	4,500 Added 0.49%	926,489 $59.2 Million
Q1 2023 Apr 27, 2023	BUY	$65.71 - $74.53 $6.64 Million - $7.53 Million	101,000 Added 12.3%	921,989 $63.9 Million
Q4 2022 Feb 03, 2023	BUY	$68.48 - $81.09 $13,696 - $16,218	200 Added 0.02%	820,989 $59.1 Million
Q3 2022 Nov 07, 2022	SELL	$0.13 - $76.84 $3,432 - $2.03 Million	-26,400 Reduced 3.12%	820,789 $58.4 Million
Q1 2022 May 12, 2022	SELL	$61.48 - $73.72 $7.8 Million - $9.36 Million	-126,900 Reduced 13.03%	847,189 $61.9 Million
Q4 2021 Feb 07, 2022	SELL	$53.63 - $62.52 $386,136 - $450,144	-7,200 Reduced 0.73%	974,089 $60.7 Million
Q3 2021 Nov 05, 2021	BUY	$59.17 - $69.31 $230,763 - $270,309	3,900 Added 0.4%	981,289 $58.1 Million
Q2 2021 Aug 02, 2021	SELL	$61.91 - $67.42 $841,976 - $916,912	-13,600 Reduced 1.37%	977,389 $65.3 Million
Q1 2021 May 07, 2021	SELL	$59.34 - $66.74 $3 Million - $3.37 Million	-50,500 Reduced 4.85%	990,989 $62.6 Million
Q4 2020 Feb 10, 2021	SELL	$57.74 - $65.43 $1.46 Million - $1.66 Million	-25,300 Reduced 2.37%	1,041,489 $64.6 Million
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $6.79 Million - $7.52 Million	-118,200 Reduced 9.97%	1,066,789 $64.3 Million
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $87,712 - $102,544	1,600 Added 0.14%	1,184,989 $69.7 Million
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $1.59 Million - $2.31 Million	-34,288 Reduced 2.82%	1,183,389 $66 Million
Q4 2019 Feb 13, 2020	SELL	$49.21 - $64.19 $572,312 - $746,529	-11,630 Reduced 0.95%	1,217,677 $78.2 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $5.13 Million - $6.09 Million	-120,023 Reduced 8.9%	1,229,307 $62.3 Million
Q2 2019 Aug 12, 2019	SELL	$44.62 - $49.34 $45.8 Million - $50.6 Million	-1,025,670 Reduced 43.19%	1,349,330 $61.2 Million
Q1 2019 May 14, 2019	SELL	$45.12 - $53.8 $14.7 Million - $17.5 Million	-325,000 Reduced 12.04%	2,375,000 $113 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $149 Million - $172 Million	2,700,000	2,700,000 $172 Million

Others Institutions Holding BMY

# of Institutions

2,809

Shares Held

1.59B

Call Options Held

25.9M

Put Options Held

23.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.9B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Homestead Advisers Corp, based on Form 13F filings with the SEC.

News

Stay updated on Homestead Advisers Corp with notifications on news.

Account

Homestead Advisers Corp Bristol Myers Squibb CO Transaction History